This article was originally published in The Gray Sheet
Executive SummaryPMA application for Siemens' full-field digital mammography system, incorporating Hologic's DirectRay amorphous selenium detector component, will be filed by year-end, the firm says. Under an agreement with Hologic, Siemens has access to data for the DirectRay to support the submission. The selenium detector received an FDA "approvable" letter for PMA supplemental approval as part of Hologic's LORAD Selenia FFDM on July 11; full approval is expected this fall...
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.